WebJan 17, 2024 · Cardiology, obesity and ophthalmology drugs are also of interest, Micklus said. Two companies that might be M&A targets are Apellis Pharmaceuticals, which is on track to gain approval in 2024 for the first treatment for geographic atrophy, an advanced form of dry age-related macular degeneration; and Cytokinetics, a muscle biology ... Web2016. First FDA approval of a gene therapy product in the US, Luxturna™ for the treatment of inherited retinal degeneration. 2024. >35 million UEAs safely used annually in the US for …
SonoThera gets license for GE HealthCare’s Optison and Sonazoid …
WebFeb 27, 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 27, 2024-- WebSonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, today announced it has received exclusive, global, commercial licensing rights from GE HealthCare (Nasdaq: GEHC) for use of Optison® and Sonazoid® microbubble products. The ... norman real world paintings
Contact SonoThera Ultrasound-Guided Nonviral Gene Therapy
WebRegister and update the addresses and mobile numbers of your migrant workers online. Log in to OFWAS with Singpass. Service is online. Availability. 24 hours. Your Quick Introduction to Corppass. Watch on. Not available due to maintenance. Every Thursday, 8.30pm – 9pm. WebDec 5, 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, today announced completion of its $60.75M Series A financing round.The financing will support the continued development of SonoThera’s ultrasound-guided, … WebFeb 27, 2024 · “Our preclinical testing has demonstrated that the platform can address many of the key delivery challenges facing current gene therapy approaches.” SonoThera’s ultrasound-guided platform uses sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads of diverse formats and sizes, selectively … how to remove threats